Literature DB >> 22994149

EGFR overexpression in canine primary lung cancer: pathogenetic implications and impact on survival.

S Sabattini1, F R Mancini, L Marconato, B Bacci, F Rossi, M Vignoli, G Bettini.   

Abstract

This study reports the main clinicopathological features of primary lung cancer (PLC) in 37 dogs, with special regard to the pathogenetic and prognostic role of epidermal growth factor receptor (EGFR) overexpression. For each case the following characteristics were evaluated: tumour-node-metastasis (TNM) stage, tumour histotype, histological grade, mitotic activity and immunohistochemical expression of EGFR. In samples with available normal lung tissue, the amount of background anthracosis was also measured by image analysis. In 27 tumours (73%) a variable number of cells (20-100%) stained positively for EGFR. The proportion of EGFR-positive tumours was significantly higher in cases with background anthracosis, and the amount of anthracosis was correlated with the percentage of positive tumour cells. Additionally, a trend towards shortened survival for the high EGFR group was observed. These findings suggest an involvement of EGFR signalling pathway in canine PLC, a negative prognostic significance of protein overexpression and its potential implication in air pollution carcinogenesis.
© 2012 John Wiley & Sons Ltd.

Entities:  

Keywords:  EGFR; dog; lung cancer; pollution; prognosis; tyrosine kinase

Mesh:

Substances:

Year:  2012        PMID: 22994149     DOI: 10.1111/vco.12002

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  11 in total

1.  Computed tomography radiomic features hold prognostic utility for canine lung tumors: An analytical study.

Authors:  Hannah Able; Amber Wolf-Ringwall; Aaron Rendahl; Christopher P Ober; Davis M Seelig; Chris T Wilke; Jessica Lawrence
Journal:  PLoS One       Date:  2021-08-17       Impact factor: 3.240

2.  Antitumor activity of nimotuzumab in combination with cisplatin in lung cancer cell line A549 in vitro.

Authors:  Yanhong Yang; Wenwen Zhou; Jiandong Wu; Lixin Yao; Lei Xue; Qianyi Zhang; Zhenzhen Wang; Xiaoyu Wang; Shu Dong; Jiangman Zhao; Duanduan Yin
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

3.  Elevated EGF Levels in the Blood Serum of Dogs with Periodontal Diseases and Oral Tumours.

Authors:  Aleksandra Sobczyńska-Rak; Beata Żylińska; Izabela Polkowska; Tomasz Szponder
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

4.  Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients.

Authors:  Josef Singer; Judit Fazekas; Wei Wang; Marlene Weichselbaumer; Miroslawa Matz; Alexander Mader; Willibald Steinfellner; Sarah Meitz; Diana Mechtcheriakova; Yuri Sobanov; Michael Willmann; Thomas Stockner; Edzard Spillner; Renate Kunert; Erika Jensen-Jarolim
Journal:  Mol Cancer Ther       Date:  2014-04-22       Impact factor: 6.261

5.  EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model?

Authors:  Rossella Terragni; Andrea Casadei Gardini; Silvia Sabattini; Giuliano Bettini; Dino Amadori; Chiara Talamonti; Massimo Vignoli; Laura Capelli; Jimmy H Saunders; Marianna Ricci; Marianna Ricci; Paola Ulivi; Paola Ulivi
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

6.  Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.

Authors:  Fernanda B Mantovani; Jodi A Morrison; Anthony J Mutsaers
Journal:  BMC Vet Res       Date:  2016-05-31       Impact factor: 2.741

7.  Canine pulmonary adenocarcinoma tyrosine kinase receptor expression and phosphorylation.

Authors:  Evan T Mariotti; Christopher Premanandan; Gwendolen Lorch
Journal:  BMC Vet Res       Date:  2014-01-14       Impact factor: 2.741

8.  Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer.

Authors:  Sho Yoshimoto; Daiki Kato; Satoshi Kamoto; Kie Yamamoto; Masaya Tsuboi; Masahiro Shinada; Namiko Ikeda; Yuiko Tanaka; Ryohei Yoshitake; Shotaro Eto; Kohei Saeki; James Chambers; Yuko Hashimoto; Kazuyuki Uchida; Ryohei Nishimura; Takayuki Nakagawa
Journal:  J Vet Med Sci       Date:  2020-04-03       Impact factor: 1.267

9.  A Contemporary Retrospective Study of Survival in Dogs With Primary Lung Tumors: 40 Cases (2005-2017).

Authors:  Ruth J Rose; Deanna R Worley
Journal:  Front Vet Sci       Date:  2020-10-23

10.  Defucosylated Mouse-Dog Chimeric Anti-EGFR Antibody Exerts Antitumor Activities in Mouse Xenograft Models of Canine Tumors.

Authors:  Guanjie Li; Tomokazu Ohishi; Mika K Kaneko; Junko Takei; Takuya Mizuno; Manabu Kawada; Masaki Saito; Hiroyuki Suzuki; Yukinari Kato
Journal:  Cells       Date:  2021-12-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.